Deciphering tissue-induced Klebsiella pneumoniae lipid a structure

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 46, 2015, Pages E6369-E6378

  Llobet, Enrique ^a,b,c   Martínez Moliner, Verónica ^a,b,c   Moranta, David ^a,b,c   Dahlström, Käthe M ^d   Regueiro, Verónica ^a,b,c   Tomása, Anna ^a,b,c   Cano, Victoria ^a,b,c   Pérez Gutiérrez, Camino ^b,c   Frank, Christian G ^e   Fernández Carrasco, Helena ^e   Insua, José Luis ^e   Salminen, Tiina A ^d   Garmendia, Junkal ^c,f   Bengoechea, José A ^e,f  

^a Institut d'Investigació Sanitària de Palma   (Spain)

^b Laboratory Microbial Pathogenesis   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d ÅBO AKADEMI UNIVERSITY   (Finland)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f CSIC   (Spain)

Author keywords

Colistin; Klebsiella; Lipid A; LpxO; PhoPQ

Indexed keywords

BACTERIAL ENZYME; BACTERIUM LIPOPOLYSACCHARIDE; BETA DEFENSIN 2; COLISTIN; LIPID A; LPXO PROTEIN; OXYGENASE; POLYMYXIN B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATION; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LIPID ANALYSIS; LUNG LAVAGE; LUNG PARENCHYMA; MEDIATOR RELEASE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; KLEBSIELLA INFECTION; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPID A; LUNG; MICE; MOLECULAR STRUCTURE; ORGAN SPECIFICITY;

EID: 84947588328     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1508820112     Document Type: Article

References (69)

1. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635-700.
2. Raetz CR, Reynolds CM, Trent MS, Bishop RE (2007) Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76:295-329.
3. Needham BD, Trent MS (2013) Fortifying the barrier: The impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol 11(7):467-481.
4. Lee H, Hsu FF, Turk J, Groisman EA (2004) The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J Bacteriol 186(13):4124-4133.
5. Guo L, et al. (1997) Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276(5310):250-253.
6. Guo L, et al. (1998) Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95(2):189-198.
7. Gibbons HS, Reynolds CM, Guan Z, Raetz CR (2008) An inner membrane dioxygenase that generates the 2-hydroxymyristate moiety of Salmonella lipid A. Biochemistry 47(9):2814-2825.
8. Gibbons HS, Lin S, Cotter RJ, Raetz CR (2000) Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/alpha-ketoglutarate-dependent dioxygenase homologue. J Biol Chem 275(42):32940-32949.
9. Gibbons HS, Kalb SR, Cotter RJ, Raetz CR (2005) Role of Mg2+ and pH in the modification of Salmonella lipid A after endocytosis by macrophage tumour cells. Mol Microbiol 55(2):425-440.
10. Murata T, Tseng W, Guina T, Miller SI, Nikaido H (2007) PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar typhimurium. J Bacteriol 189(20):7213-7222.
11. Maeshima N, Fernandez RC (2013) Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol 3:3.
12. Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL (2014) Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 20(9):862-872.
13. El Hamidi A, Tirsoaga A, Novikov A, Hussein A, Caroff M (2005) Microextraction of bacterial lipid A: Easy and rapid method for mass spectrometric characterization. J Lipid Res 46(8):1773-1778.
14. Yi EC, Hackett M (2000) Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria. Analyst (Lond) 125(4):651-656.
15. Llobet E, Campos MA, Giménez P, Moranta D, Bengoechea JA (2011) Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors. Infect Immun 79(9):3718-3732.
16. Clements A, et al. (2007) Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem 282(21):15569-15577.
17. Moskowitz SM, Ernst RK (2010) The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection. Subcell Biochem 53:241-253.
18. Geurtsen J, et al. (2007) A novel secondary acyl chain in the lipopolysaccharide of Bordetella pertussis required for efficient infection of human macrophages. J Biol Chem 282(52):37875-37884.
19. MacArthur I, Jones JW, Goodlett DR, Ernst RK, Preston A (2011) Role of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesis. J Bacteriol 193(18):4726-4735.
20. Helander IM, et al. (1996) Characterization of lipopolysaccharides of polymyxin-resistant and polymyxin-sensitive Klebsiella pneumoniae O3. Eur J Biochem 237(1):272-278.
21. Sforza S, et al. (2004) Determination of fatty acid positions in native lipid A by positive and negative electrospray ionization mass spectrometry. J Mass Spectrom 39(4):378-383.
22. McGinnis K, et al. (1996) Site-directed mutagenesis of residues in a conserved region of bovine aspartyl (asparaginyl) beta-hydroxylase: Evidence that histidine 675 has a role in binding Fe2+. Biochemistry 35(13):3957-3962.
23. Fresno S, et al. (2006) The ionic interaction of Klebsiella pneumoniae K2 capsule and core lipopolysaccharide. Microbiology 152(Pt 6):1807-1818.
24. Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20:55-72.
25. Nizet V (2006) Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 8(1):11-26.
26. Hiratsuka T, et al. (1998) Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 249(3):943-947.
27. Li J, et al. (2006) Colistin: The re-emerging antibiotic for multidrug-resistant Gramnegative bacterial infections. Lancet Infect Dis 6(9):589-601.
28. Kato A, Latifi T, Groisman EA (2003) Closing the loop: The PmrA/PmrB two-component system negatively controls expression of its posttranscriptional activator PmrD. Proc Natl Acad Sci USA 100(8):4706-4711.
29. García Véscovi E, Soncini FC, Groisman EA (1996) Mg2+ as an extracellular signal: Environmental regulation of Salmonella virulence. Cell 84(1):165-174.
30. Hicks KG, et al. (2015) Acidic pH and divalent cation sensing by PhoQ are dispensable for systemic salmonellae virulence. eLife 4:e06792.
31. Prost LR, Daley ME, Bader MW, Klevit RE, Miller SI (2008) The PhoQ histidine kinases of Salmonella and Pseudomonas spp. are structurally and functionally different: Evidence that pH and antimicrobial peptide sensing contribute to mammalian pathogenesis. Mol Microbiol 69(2):503-519.
32. Prost LR, et al. (2007) Activation of the bacterial sensor kinase PhoQ by acidic pH. Mol Cell 26(2):165-174.
33. Frank CG, et al. (2013) Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation. Cell Microbiol 15(7):1212-1233.
34. Tomás A, et al. (2015) Functional genomic screen identifies klebsiella pneumoniae factors implicated in blocking nuclear factor kappaB (NF-kappaB) signaling. J Biol Chem 290(27):16678-16697.
35. March C, et al. (2011) Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells. J Biol Chem 286(12):9956-9967.
36. Moranta D, et al. (2010) Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells. Infect Immun 78(3):1135-1146.
37. Regueiro V, Campos MA, Pons J, Albertí S, Bengoechea JA (2006) The uptake of a Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells. Microbiology 152(Pt 2):555-566.
38. Regueiro V, et al. (2011) Klebsiella pneumoniae subverts the activation of inflammatory responses in a NOD1-dependent manner. Cell Microbiol 13(1):135-153.
39. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67(4):593-656.
40. Breidenstein EB, De La Fuente-Núñez C, Hancock RE (2011) Pseudomonas aeruginosa: All roads lead to resistance. Trends Microbiol 19(8):419-426.
41. Gooderham WJ, Hancock RE (2009) Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev 33(2):279-294.
42. De Majumdar S, et al. (2015) Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulation. PLoS Pathog 11(1):e1004627.
43. Holt KE, et al. (2015) Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci USA 112(27):E3574-E3581.
44. Lery LM, et al. (2014) Comparative analysis of klebsiella pneumoniae genomes identifies a phospholipase D family protein as a novel virulence factor. BMC Biol 12:41-56.
45. Brisse S, et al. (2009) Virulent clones of Klebsiella pneumoniae: Identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4(3):e4982.
46. Llobet E, Tomás JM, Bengoechea JA (2008) Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154(Pt 12):3877-3886.
47. Derbise A, Lesic B, Dacheux D, Ghigo JM, Carniel E (2003) A rapid and simple method for inactivating chromosomal genes in Yersinia. FEMS Immunol Med Microbiol 38(2):113-116.
48. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP (1998) A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomal ly-located DNA sequences: Application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212(1):77-86.
49. Alexeyev MF (1999) The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of gramnegative bacteria. Biotechniques 26(5):824-826, 828.
50. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97(12):6640-6645.
51. Favre D, Viret JF (2000) Gene replacement in gram-negative bacteria: The pMAKSAC vectors. Biotechniques 28(2):198-200, 202, 204.
52. Crépin S, Harel J, Dozois CM (2012) Chromosomal complementation using Tn7 transposon vectors in Enterobacteriaceae. Appl Environ Microbiol 78(17):6001-6008.
53. Michiels T, Wattiau P, Brasseur R, Ruysschaert JM, Cornelis G (1990) Secretion of yop proteins by yersiniae. Infect Immun 58(9):2840-2849.
54. Byrappa S, Gavin DK, Gupta KC (1995) A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase. Genome Res 5(4):404-407.
55. Cai S, Batra S, Wakamatsu N, Pacher P, Jeyaseelan S (2012) NLRC4 inflammasomemediated production of IL-1p modulates mucosal immunity in the lung against gramnegative bacterial infection. J Immunol 188(11):5623-5635.
56. Lindner B (2000) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of lipopolysaccharides. Methods Mol Biol 145:311-325.
57. Bengoechea JA, Díaz R, Moriyón I (1996) Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides. Infect Immun 64(12):4891-4899.
58. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ (2000) Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165(2):618-622.
59. Tirsoaga A, et al. (2007) Simple method for repurification of endotoxins for biological use. Appl Environ Microbiol 73(6):1803-1808.
60. Caroff M, Tacken A, Szabó L (1988) Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin. Carbohydr Res 175(2):273-282.
61. Gunn JS, Miller SI (1996) PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 178(23):6857-6864.
62. Johnson MS, May AC, Rodionov MA, Overington JP (1996) Discrimination of common protein folds: Application of protein structure to sequence/structure comparisons. Methods Enzymol 266:575-598.
63. Lehtonen JV, et al. (2004) BODIL: A molecular modeling environment for structurefunction analysis and drug design. J Comput Aided Mol Des 18(6):401-419.
64. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234(3):779-815.
65. Benkert P, Kunzli M, Schwede T (2009) QMEAN server for protein model quality estimation. Nucleic Acids Res 37 (Web Server issue):W510-W514.
66. Wiederstein M, Sippl MJ (2007) ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35 (Web Server issue):W407-W410.
67. McGuffin LJ, Roche DB (2010) Rapid model quality assessment for protein structure predictions using the comparison of multiple models without structural alignments. Bioinformatics 26(2):182-188.
68. Laskowski RA (1995) SURFNET: A program for visualizing molecular surfaces, cavities, and intermolecular interactions. J Mol Graph 13(5):307-308.
69. Martí-Lliteras P, et al. (2009) Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect Immun 77(10):4232-4242.